ENL vs IVX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ENL

ENLITIC CDI FORUS [ENL]

38LOW

IVX

INVION FPO [IVX]

38LOW

Score Breakdown

ENL IVX
Technical
60
54
Catalyst
50
53
Sentiment
50
50
Fundamental
59
17
Momentum
36
44
Risk Gate
24
45

Key Metrics

ENL Metric IVX
$5.8MMarket Cap$7.4M
2.4MAvg Volume (20d)78K
+0.1%Short InterestN/A
$0.08252-Week High$0.200
$0.00652-Week Low$0.075
+0.0%Daily Change+0.0%
$0.007Entry Price$0.076
-177.1%ROE-111.5%
N/AProfit MarginN/A

Active Signals

ENL Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Volume surging at 5.1x normal while price falls — heavy selling pressure
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.9 quarters)
Low P/S ratio (1.5x)

IVX Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.2 quarters)
Pre-revenue with limited cash
Piotroski F-Score weak (2/9, low-confidence approx)

Ask Scout AI to compare ENL and IVX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ENL Full Analysis → IVX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).